These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 170856)

  • 81. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.
    Retsema JA; English AR; Girard A; Lynch JE; Anderson M; Brennan L; Cimochowski C; Faiella J; Norcia W; Sawyer P
    Rev Infect Dis; 1986; 8 Suppl 5():S528-34. PubMed ID: 3026001
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Changes in serotype and resistance pattern of the intestinal Escherichia coli flora during travel. Results from a trial of mecillinam as a prophylactic against travellers' diarrhoea.
    Stenderup J; Orskov I; Orskov F
    Scand J Infect Dis; 1983; 15(4):367-73. PubMed ID: 6318304
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Lampri N; Galani I; Poulakou G; Katsarolis I; Petrikkos G; Giamarellou H; Souli M
    J Antimicrob Chemother; 2012 Oct; 67(10):2424-8. PubMed ID: 22665388
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Susceptibility to mecillinam and other antibiotics of 28 O-serotypes of Yersinia enterocolitica.
    Juhlin I; Winblad S
    J Antimicrob Chemother; 1981 Oct; 8(4):291-7. PubMed ID: 6271722
    [No Abstract]   [Full Text] [Related]  

  • 85. Bactericidal activity of the ampicillin-kanamycin combination against Escherichia coli, Enterobacter-Klebsiella and Proteus.
    Bulger RJ; Roosen-Runge U
    Am J Med Sci; 1969 Jul; 258(1):7-13. PubMed ID: 4894496
    [No Abstract]   [Full Text] [Related]  

  • 86. 6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterization.
    Moore BA; Brammer KW
    Antimicrob Agents Chemother; 1981 Sep; 20(3):327-31. PubMed ID: 6272628
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.
    Zhanel GG; Karlowsky JA; Schwartz B; Jensen SB; Hoban DJ
    Chemotherapy; 1998; 44(6):391-6. PubMed ID: 9755298
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas species.
    Fass RJ
    Antimicrob Agents Chemother; 1981 Feb; 19(2):361-3. PubMed ID: 6289732
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.
    Marre R; Schulz E
    Arzneimittelforschung; 1988 Jul; 38(7):863-5. PubMed ID: 3061383
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
    Gatermann S; Marre R
    Infection; 1991; 19(2):106-9. PubMed ID: 1646771
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W; Binder S; Stieglitz M
    Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cluster of mrdA and mrdB genes responsible for the rod shape and mecillinam sensitivity of Escherichia coli.
    Tamaki S; Matsuzawa H; Matsuhashi M
    J Bacteriol; 1980 Jan; 141(1):52-7. PubMed ID: 6243629
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Plotting regression lines for a new beta-lactam antibiotic (mecillinam).
    Roser H; Mielenz H; Koser C
    Int J Clin Pharmacol Biopharm; 1977 Nov; 15(11):531-41. PubMed ID: 201578
    [TBL] [Abstract][Full Text] [Related]  

  • 94. 6 -amidinopenicillanic acids--a new group of antibiotics.
    Lund F; Tybring L
    Nat New Biol; 1972 Apr; 236(66):135-7. PubMed ID: 4402006
    [No Abstract]   [Full Text] [Related]  

  • 95. Study of the enhancement of beta-lactam activity by amdinocillin in a model of the human urinary bladder.
    Anderson JD; Eftekhar F
    Am J Med; 1983 Aug; 75(2A):42-7. PubMed ID: 6311004
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Antibacterial properties of alafosfalin combined with cephalexin.
    Atherton FR; Hall MJ; Hassall CH; Holmes SW; Lambert RW; Lloyd WJ; Nisbet LJ; Ringrose PS; Westmacott D
    Antimicrob Agents Chemother; 1981 Oct; 20(4):470-6. PubMed ID: 7044291
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Sulbactam: biochemical factors involved in its synergy with ampicillin.
    Labia R; Morand A; Lelievre V; Mattioni D; Kazmierczak A
    Rev Infect Dis; 1986; 8 Suppl 5():S496-502. PubMed ID: 3025996
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect of combination of cefsulodin and mecillinam.
    Kondo M; Tsuchiya K
    J Antibiot (Tokyo); 1981 Jun; 34(6):727-38. PubMed ID: 6268593
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Potential prodrugs of 6-acetylmethylenepenicillanic acid (Ro 15-1903).
    Adam S; Then R; Angehrn P
    J Antibiot (Tokyo); 1986 Jun; 39(6):833-8. PubMed ID: 3015853
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Synergy of sulbactam and ampicillin against methicillin-resistant staphylococci.
    Chin NX; Neu NM; Neu HC
    Drugs Exp Clin Res; 1986; 12(12):939-42. PubMed ID: 3032552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.